Inhibition of Cell Cycle Progression and Induction of Apoptosis in HeLa Cells by HY558-1, a Novel CDK Inhibitor Isolated from Penicillium minioluteum F558
![]() |
Lim, Hae-Young
(Department of Medical Genetics and Institute of Biomedical Science, Hanyang University)
Kim, Min-Kyoung (Department of Medical Genetics and Institute of Biomedical Science, Hanyang University) Cho, Youl-Hee (Department of Medical Genetics and Institute of Biomedical Science, Hanyang University) Kim, Jung-Mogg (Department of Microbiology, College of Medicine, Hanyang University) Lim, Yoong-Ho (Bio/Molecular Informatics Center, Konkuk University) Lee, Chul-Hoon (Department of Medical Genetics and Institute of Biomedical Science, Hanyang University) |
1 | El-Deiry, W. S., T. Tokino, V. E. Velculescu, D. B. Levy, R. Parsons, J. M. Trent,D. Lin, W. E. Mercer, K. W. Kinzler, and B. Voglstein. 1993. WAF1, a potential mediator of p53 tumor suppression. Cell 75: 817-825. |
2 | King, R. W., P. K. Jackson, and M. W. Kirschner. 1994. Mitosis in transition. Cell 79: 563- 571. |
3 | Knudsen, E. S. and J. Y Wang. 1997. Dual mechanisms for the inhibition of E2F binding to RB by cyclin-dependent kinase-mediated RB phosphorylation. Mol. Cell. BioI. 17: 5771-5783. |
4 | Polyak, K., M. H. Lee, H. Erdjument-Bromage, A. Koff, J. M. Roberts, P. Tempst, and J. Massague. 1994. Cloning of p27Kipl, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals. Cell 78: 5966. |
5 | Sherr, C. J. and J. M. Roberts. 1999. CDK inhibitors: Positive and negative regulators of Gl phase progression. Genes Dev. 13: 1501-1512. |
6 | Song, J., S. Kim, Y Lee, K. Lee, H. Jung, M. Kim, K. Kim, R. Brown, and Y. Kim. 2002. Adenovirus-mediated antisense expression of telomerase template RNA induces apoptosis in lung cancer cells. J. Microbiol. Biotechnol. 12(1): 89- 95. |
7 | Stennicke, H. R., J. M. Jurgensmeier, H. Shin, Hwain Shin, Q. Deveraux, B. B. Wolf, X. Yang, Q. Zhou, H. M. Ellerby, L. M. Ellerby, D. Bredesen, D. R. Green, J. C. Reed, C. J. Froelich, and G. S. Salvesen. 1998. Pro-caspase-3 is a major physiologic target of caspase-8. J. BioI. Chem. 273: 27084-27090. |
8 | Stennicke, H. R. and G. S. Salvesen. 1998. Properties of the caspases. Biochim. Biophys. Acta 1387: 17-31. |
9 | Matsushime, H., M. F. Roussel, R. A. Ashmun, and C. J. Sherr. 1991. Colony-stimulating factor 1 regulates novel cyclins during the G1 phase of the cell cycle. Cell 65: 701-713. |
10 | Park, H., D. Jun, and Y. Kim. 2002. Apoptotic activity of insect pathogenic fungus Paecilomyces japonica toward human acute leukemia jurkat T cells is associated with mitochondria-dependent caspase-3 activation regulated by Bci-2. J. Microbiol. Biotechnol. 12: 950- 956. |
11 | Viswanath, V., Y Wu, R. Boonplueang, S. Chen, F. F. Stevenson, F. Yantiri, L. Yang, F. Beal, and J. K. Anderson. 2001. Caspase-9 activation results in downstream caspase-8 activation and Bid cleavage in I-methyl-4-phenyl-l,2,3,6tetrahydropyridine- induced Parkinsons disease. J. Neurosci. 21: 9519- 9528. |
12 | Lee, H., M. Jang, J. Choi, Y Lee, H. Park, Y. Lee, S. Kim, and M. Ahn. 2003. Proliferation, apoptosis, and telomerase activity in human cord blood CD34(+) cells cultured with combinations of various cytokines. J. Microbial. Biotechnol. 13(3): 422- 428. |
13 | Zha, J., S. Weiler, K. J. Oh, M. C. Wei, and S. J. Korsmeyer. 2000. Posttranslational N-myristoylation of Bid as a molecular switch for targeting mitochondria and apoptosis. Science 290: 1761-1765. |
14 | Kim, M., Y Cho, J. Kim, M. Chun, S. Lee, Y Lim, and C.-H. Lee. 2003. Inhibition of cell-cycle progression in human promyeloc:ytic leukemia HL-60 cells by MCS-C2, novel cyclin-dependent kinase inhibitor.J. Microbiol. Biotechnol. 13: 607- 612. |
15 | Lundberg, A. S. and R. A. Weinberg. 1998. Functional inactivation of the retinoblastoma protein requires sequential modification by at least two distinct cyclin-cdk complexes. Mol. Cell. BioI. 18: 753- 761. |
16 | Li, H., H. Zhu, C. J. Xu, and J. Yuan. 1998. Cleavage of Bid by caspase 8 mediates the motochondrial damage in the Fas pathway of apoptosis, Cell 94: 491- 501. |
17 | Harper, J. W. and S. J. Elledge. 1996. Cdk inhibitor in development and cancer. Curro Opin. Genet. Dev. 6: 56- 64. |
18 | Rhee, W. J. and T. H. Park. 2001. Flow cytometric analysis of silkworm hemolymph on the baculovirus-induced insect cell apoptosis. J. Microbiol. Biotechnol. 11: 853- 857. |
19 | Green, D. R. 1998. Apoptotic pathway: The roads to ruin. Cell 94: 695- 698. |
20 | Hunter, T. and J. Pines. 1994. Cyclins and cancer. CyclinD andCDKinhibitors come of age. Cell 79: 573- 582. |
21 | Tang, D., J. M. Lahti, and V. J. Kidd. 2000. Caspase-8 activation and Bid cleavage contribute to MCF7 cellular execution in a caspase-3-dependent manner during Staurosporine-mediated apoptosis. J. BioI. Chem. 275: 9303- 9307. |
22 | Lee, C.-H., H. Lim, M. K. Kim, Y-H. Cho, D.-K. Oh, C.-J. Kim, and Y. Lim. 2002. Isolation and biological properties of novel cell cycle inhibitor, HY558, isolated from Penicillium minioluteum F558. J. Microbiol. Biotechnol. 12: 470- 475. |
23 | Dantzer, E., V. Schreiber, C. Niedergang, C. Trucco, E. Flatter, G. De La Rubia, J. Oliver, V. Rolli, J. Menissier-de Murcia, and G. de Murcia. 1999. Involvement of poly(ADPribose) polymerase in base excision repair. Biochimie 81: 69-75. |
24 | Ashkenazi, A. and V. M. Dixit. 1998. Death receptors: signaling and modulation. Science 281: 1305- 1308. |
25 | Morgan, D. O. 1995. Principles of CDK regulation. Nature 374: 131- 134. DOI PUBMED ScienceOn |
26 | Sherr, C. J. 1993. Mammalian G1 cyclins. Cell 73: 1059-1065. PUBMED |
27 | Gross, A., X. M. Yin, K. Wang, M. C. Wei, J. Jockel, C. Milliman, H. Erdjument-Bromage, P. Tempst, and S. J. Korsmeyer. 1999. Caspase cleaved Bid target mitochondria and is required for cytochrome c release, while Bcl-xl prevents this release but not tumor necrosis factor-Rl/Fas death. J. Biol. Chem. 274: 1156- 1163. |
28 | Luo, X., I. Budihardjo, H. Zou, C. Slaughter, and X. Wang. 1998. Bid, a Bcl2 interacting protein, mediates cytochrome c release from mitochondria in response to activation of cell death receptors. Cell 94: 481- 490. |
29 | Guadagno, T. M. and J. W. Newport. 1996. Cdk2 kinase is required for entry into mitosis as a positive regulator of cdc2-cyclin B kinaseactivity. Cell 84: 73- 82. |
30 | Lee, C.-H., M. Lee, Y. Cho, H. Lim, J. Jung, K. H. Kim, and Y. Lim. 200I. In vitro detection of apoptosis in human promyelocytic leukemia HL-60 cells by H-NMR. J. Microbiol. Biotechnol. 11: 539- 542. |
31 | Weinberg, R. A. 1995. The retinoblastoma protein and cell cycle control. Cell 81: 323- 330. DOI PUBMED ScienceOn |
32 | Green, D. R. and J. C. Reed. 1998. Mitochondria and apoptosis. Science 281: 1309- 1312. |
33 | Jeong, Y, K. Kim, J. Oh, J. Park, J. Bang, S. Choi, and J. Lee. 2003. Growth inhibition and apoptosis induction of gastric cancer by copper (II) glycinate complex. J. Microbiol. Biotechnol. 13: 394- 399. |
![]() |